Depression Screening May Unlock new Asthma Treatment Strategies, Especially in Children
A study in the Journal of Allergy and Clinical Immunology: Global suggests screening asthma patients for depression may improve outcomes, especially in those with difficult-to-control disease.
Key Findings – Researchers found a link between depression and asthma,indicating anticholinergic therapies could be beneficial,particularly for children experiencing both.
Asthma Statistics – Asthma affects 26 million Americans, including 4.5 million children. in 2019, there were over 1.8 million asthma-related emergency room visits and roughly 3,500 deaths in 2021.
Mental Health Link – Depressive and anxiety symptoms can complicate asthma control. Adults and children with asthma report higher levels of depressive symptoms than those with most other chronic illnesses.
Anticholinergic Therapy – The study explored whether inhaled anticholinergic medicines like ipratropium could help, as depression can increase airway constriction. Children with higher depression scores showed greater advancement in lung function after ipratropium use.
Study Details – Researchers screened 39 children (average age 12.9) for depressive symptoms. Participants showed clinically significant depression,and those with higher scores responded more positively to ipratropium.
Keep reading
